{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T11:47:57Z","timestamp":1772106477592,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1007\/s00108-004-1316-2","type":"journal-article","created":{"date-parts":[[2004,12,3]],"date-time":"2004-12-03T15:36:36Z","timestamp":1102088196000},"page":"30-38","source":"Crossref","is-referenced-by-count":1,"title":["Akutes Nierenversagen","Acute renal failure"],"prefix":"10.1007","volume":"46","author":[{"given":"M.","family":"Krych","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0270-9295(03)00089-5","volume":"23","author":"Arany","year":"2003","unstructured":"Arany I, Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23: 460?464","journal-title":"Semin Nephrol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/annonc\/mdh029","volume":"15","author":"Berg van den","year":"2004","unstructured":"Berg H van den, Reintsema AM (2004) Renal tubular damage in rasburicase: risks of alkalinisation. Ann Oncol 15: 175?176","journal-title":"Ann Oncol"},{"key":"CR3","unstructured":"Bishop MR, Coccia PF (2000) Tumor lysis syndrome. In: Abeloff MD et al. (ed) Clinical oncology. Churchill Livingstone, New York, pp 750?754"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","volume":"127","author":"Cairo","year":"2004","unstructured":"Cairo MS, Bishop P (2004) Tumor lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127: 3?11","journal-title":"Br J Haematol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.amjmed.2003.09.045","volume":"116","author":"Davidson","year":"2004","unstructured":"Davidson MB, Thakkar S, Hix JK et al. (2004) Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med 116: 546?554","journal-title":"Am J Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1046\/j.1523-1755.2003.00936.x","volume":"63","author":"Fadia","year":"2003","unstructured":"Fadia A, Casserly LF, Sanchorawala V et al. (2003) Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis. Kidney Int 63: 1868?1673","journal-title":"Kidney Int"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1182\/blood.V97.10.2998","volume":"97","author":"Goldmann","year":"2001","unstructured":"Goldmann SC, Holcenberg JS, Finklestein JZ et al. (2001) A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukaemia at high risk for tumor lysis. Blood 97: 2998?3003","journal-title":"Blood"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s007610050476","volume":"5","author":"Jakob","year":"1999","unstructured":"Jakob A, Kanz L, Bokemeyer C (1999) Metabolische St\u00f6rungen als Notfall bei onkologischen Erkrankungen. Onkologie 5: 1066?1074","journal-title":"Onkologie"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF00860751","volume":"9","author":"Jones","year":"1995","unstructured":"Jones DP, Mahmoud H, Chensey RW (1995) Tumor lysis syndrome: pathogenesis and management. Pediatr Nephrol 9: 206?212","journal-title":"Pediatr Nephrol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s001080050765","volume":"42","author":"J\u00f6rres","year":"2001","unstructured":"J\u00f6rres A, Frei U (2001) Akutes Nierenversagen. Internist 42: 379?403","journal-title":"Internist"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1526-0968.2001.00301.x","volume":"5","author":"Kaplan","year":"2001","unstructured":"Kaplan AA (2001) Therapeutic apheresis for the renal complications of multiple myeloma an the dysglobulinaemias. Ther Apher 5: 165?172","journal-title":"Ther Apher"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0749-0704(05)70199-8","volume":"17","author":"Kapoor","year":"2001","unstructured":"Kapoor M, Chan GZ (2001) Malignancy and renal disease. Crit Care Clin 17: 571?598","journal-title":"Crit Care Clin"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/08880019509029545","volume":"12","author":"Kedar","year":"1995","unstructured":"Kedar A, Grow W, Neiberger RE (1995) Clinical versus laboratory tumor lysis syndrome in children with acute leukaemia. Pediatr Haematol Oncol 12: 129?134","journal-title":"Pediatr Haematol Oncol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003088-200140010-00004","volume":"40","author":"Kerbusch","year":"2001","unstructured":"Kerbusch T, de Kraker J, Keizer HJ et al. (2001) Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites. Clin Pharmacokinet 40: 41?62","journal-title":"Clin Pharmacokinet"},{"key":"CR15","first-page":"3679","volume":"20","author":"Kern","year":"2000","unstructured":"Kern W, Braess J, Kaufmann CC, Wilde S, Schleyer E, Hiddemann W (2000) Microalbuminuria during cisplatin therapy: relation with pharmacokinetics and implications for nephroprotection. Anticancer Res 20: 3679?3688","journal-title":"Anticancer Res"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200124010-00003","volume":"24","author":"Kintzel","year":"2001","unstructured":"Kintzel PE (2001) Anticancer drug-induced kidney disorders. Drug Safety 24: 19?38","journal-title":"Drug Safety"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0305-7372(95)90010-1","volume":"21","author":"Kintzel","year":"1995","unstructured":"Kintzel PE, Dorr RT (1995) Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function. Cancer Treat Rev 21: 33?64","journal-title":"Cancer Treat Rev"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1055\/s-2004-826887","volume":"129","author":"Krych","year":"2004","unstructured":"Krych M, Dreyling M, Kneba M, Hoelzer D, Hiddemann W, Hallek MD (2004) Prophylaxe und differentielle Therapie des Tumorlysesyndroms. Dtsch Med Wochenschr 129: 1440?1445","journal-title":"Dtsch Med Wochenschr"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.bmt.1704440","volume":"33","author":"Lee","year":"2004","unstructured":"Lee CK, Zangari M, Barlogie B et al. (2004) Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant. Bone Marrow Transplant 33: 823?828","journal-title":"Bone Marrow Transplant"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S0272-6386(04)00985-0","volume":"44","author":"Mistry","year":"2004","unstructured":"Mistry B, Kimmel PL, Hetzel PC, Phillips TM, Braden GL (2004) The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndrome. Am J Kidney Dis 44: e50?58","journal-title":"Am J Kidney Dis"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00392-002-0865-4","volume":"91","author":"M\u00f6ckel","year":"2002","unstructured":"M\u00f6ckel M, Bahr F, Leuner Ch, Kuhn H, Dietz R (2002) Empfehlungen zur Prophylaxe der durch R\u00f6ntgen-Kontrastmittel (RKM) induzierten Nephropathie. Z Kardiol 91: 719?726","journal-title":"Z Kardiol"},{"key":"CR22","first-page":"report","volume":"therapy","author":"Muller","year":"2004","unstructured":"Muller S, Schutt P, Bojko P et al. (2004) Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Ann Hematol [Epub ahead of print]","journal-title":"Hemolytic uremic syndrome following prolonged gemcitabine"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1159\/000052512","volume":"39","author":"Orihuela","year":"2001","unstructured":"Orihuela E, Nazemi T, Shu T (2001) Acute renal failure due to rhabdomyolysis associated with radical perineal prostatectomy. Eur Urol 39: 606?609","journal-title":"Eur Urol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/sim.4780101104","volume":"10","author":"O?Quigley","year":"1991","unstructured":"O?Quigley J, Chevret S (1991) Methods for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study. Stat Med 10: 1647?1664","journal-title":"Stat Med"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ijc.20202","volume":"111","author":"Polycarpe","year":"2004","unstructured":"Polycarpe E, Arnould L, Schmitt E et al. (2004) Low urine osmolarity as a determinant of cisplatin-induced nephrotoxicity. Int J Cancer 111: 131?137","journal-title":"Int J Cancer"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-197803010-00001","volume":"8","author":"Shen","year":"1978","unstructured":"Shen DD, Azarnoff DL (1978) Clinical pharmacokinetics of methotrexate. Clin Pharmacokin 8: 1?18","journal-title":"Clin Pharmacokin"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1072-7515(98)00089-1","volume":"186","author":"Slater","year":"1998","unstructured":"Slater MS, Mullins RJ (1998) Rhabdomyolysis and myoglobinuric renal failure in trauma and surgical patients. J Am Coll Surg 186: 693?716","journal-title":"J Am Coll Surg"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1200\/JCO.2000.18.8.1758","volume":"18","author":"Smalley","year":"2000","unstructured":"Smalley RV, Guaspari A, Haase-Statz S et al. (2000) Allopurinol: Intravenous use for prevention and treatment of hyperuricaemia. J Clin Oncol 18: 1758?1763","journal-title":"J Clin Oncol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/(SICI)1096-911X(199807)31:1<27::AID-MPO6>3.0.CO;2-1","volume":"31","author":"Ten Harkel","year":"1998","unstructured":"Ten Harkel ADJ, Kist-Van Holte JE, Van Well M et al. (1998) Alkalinization and the tumor lysis syndrome. Medical Pediatr Oncol 31: 27?28","journal-title":"Medical Pediatr Oncol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/08880019409141909","volume":"11","author":"Wechsler","year":"1994","unstructured":"Wechsler DS, Kastan MB, Fivush BA (1994) Resolution of nephrocalcinosis associated with tumor lysis syndrome. Pediatr Haematol Oncol 11: 115?118","journal-title":"Pediatr Haematol Oncol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ki.1996.48","volume":"49","author":"Zager","year":"1996","unstructured":"Zager RA (1996) Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 49: 314?326","journal-title":"Kidney Int"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ki.1988.127","volume":"33","author":"Zucchelli","year":"1988","unstructured":"Zucchelli P, Pasquali S, Cagnoli L et al. (1988) Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int 33: 1175?1189","journal-title":"Kidney Int"},{"key":"CR33","first-page":"484","volume":"31","author":"Zippel","year":"2002","unstructured":"Zippel RM (2002) Tumorlysesyndrom, tubul\u00e4re Obstruktion, Cisplatin. Nieren Hochdruckkrankh 31: 484?488","journal-title":"Nieren Hochdruckkrankh"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-004-1316-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-004-1316-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-004-1316-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T13:31:30Z","timestamp":1586007090000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-004-1316-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["1316"],"URL":"https:\/\/doi.org\/10.1007\/s00108-004-1316-2","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}